## Preoperative Management of Pheochromocytoma in MEN 2A ### Clinical Context Pheochromocytomas occur in 50% of MEN 2A patients and are often bilateral. Preoperative pharmacological preparation is essential to prevent intraoperative hypertensive crisis and arrhythmias during tumor manipulation. ### Drug of Choice: Phenoxybenzamine **Key Point:** Phenoxybenzamine, a non-selective alpha-adrenergic antagonist, is the gold-standard first-line drug for preoperative preparation of pheochromocytoma. **High-Yield:** Phenoxybenzamine is preferred because it: - Provides irreversible, non-competitive alpha-blockade - Achieves sustained blood pressure control - Prevents catecholamine-induced hypertensive surges during surgery - Allows restoration of intravascular volume (which is depleted due to chronic catecholamine-induced vasoconstriction) - Reduces perioperative morbidity and mortality ### Mechanism of Action Phenoxybenzamine irreversibly binds to alpha-1 and alpha-2 adrenergic receptors, blocking the vasoconstrictive effects of catecholamines. This prevents sudden hypertensive crises. ### Preoperative Protocol for Pheochromocytoma ```mermaid flowchart TD A[Pheochromocytoma diagnosed]:::outcome --> B[Start phenoxybenzamine]:::action B --> C[Titrate to BP control & symptom relief]:::action C --> D[Target: SBP 140-160 mmHg, HR 80-100]:::decision D --> E[After 7-10 days of alpha-blockade]:::action E --> F[Add beta-blocker if tachycardia persists]:::action F --> G[Ensure adequate hydration]:::action G --> H[Proceed to surgical resection]:::action H --> I[Intraoperative monitoring & management]:::outcome ``` ### Dosing and Titration - **Phenoxybenzamine:** Start 10 mg once or twice daily - Increase by 10–20 mg every 2–3 days - Target dose: 40–80 mg/day (divided doses) - Goal: achieve blood pressure control (SBP 140–160 mmHg) and symptom resolution - Duration: typically 7–14 days before surgery ### Why Beta-Blockers Are Secondary **Warning:** Beta-blockers (propranolol, atenolol) MUST NEVER be given before alpha-blockade is established. Unopposed beta-blockade can paradoxically worsen hypertension by removing beta-2-mediated vasodilation, leaving only alpha-adrenergic vasoconstriction unopposed. **Clinical Pearl:** The correct sequence is: 1. **Alpha-blockade first** (phenoxybenzamine) 2. **Then beta-blockade** (if tachycardia persists after alpha-blockade) 3. Beta-blockers are used to control reflex tachycardia caused by alpha-blockade, NOT as first-line agents ### Comparison of Alpha-Blocking Agents | Agent | Type | Onset | Duration | Preop Use | |-------|------|-------|----------|----------| | Phenoxybenzamine | Non-selective, irreversible | Slow (1–2 hrs) | Long (24–48 hrs) | **Gold standard** | | Doxazosin | Selective alpha-1, reversible | Moderate | Moderate (12–24 hrs) | Alternative | | Prazosin | Selective alpha-1, reversible | Moderate | Short (6–12 hrs) | Less preferred | | Nifedipine | Calcium channel blocker | Variable | Variable | Not first-line | ### Intraoperative Considerations - Anesthesiologist must be aware of pheochromocytoma - Avoid medications that trigger catecholamine release (atropine, desflurane) - Prepare for sudden hypertensive surges during tumor manipulation - Have IV phentolamine available for acute hypertensive crisis - Monitor for hypotension post-tumor removal (due to sudden loss of catecholamine source) **Clinical Pearl:** After tumor removal, patients often become hypotensive due to loss of catecholamine stimulus. Fluid resuscitation and vasopressor support may be needed. ### Bilateral Pheochromocytomas in MEN 2A MEN 2A pheochromocytomas are bilateral in 50–80% of cases. Bilateral adrenalectomy may be necessary, requiring long-term glucocorticoid and mineralocorticoid replacement. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.